Stay updated on Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.
Latest updates to the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page
- Check3 days agoNo Change Detected
- Check10 days agoChange DetectedThe website has been updated to version v2.10.3 with new additions from late August 2024, while the previous version v2.10.2 and its June 2024 entries have been removed.SummaryDifference0.5%
- Check17 days agoNo Change Detected
- Check24 days agoNo Change Detected
- Check31 days agoChange DetectedThe website has been updated from version 2.10.0 to 2.10.2, indicating new features or improvements.SummaryDifference0.1%
- Check53 days agoChange DetectedThe study has been updated to version v2.10.0 and now includes 7 locations, replacing the previous version v2.9.7.SummaryDifference0.3%
- Check60 days agoChange DetectedThe website has been updated to Revision v2.9.7 from v2.9.6.SummaryDifference0.1%
- Check74 days agoChange DetectedThe value of Revision has been updated from v2.9.5 to v2.9.6, indicating a recent revision in the content of the webpage.SummaryDifference0.1%
- Check79 days agoChange DetectedThe value of Last Update Posted (Estimated) Revision has changed from v2.9.3 to v2.9.5, indicating an update to the study record details on the webpage.SummaryDifference0.1%
Stay in the know with updates to Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs BCG in High-Risk NMIBC & NMI-UTUC Clinical Trial page.